-
CSR Summary Not Yet Available
-
NCT00207727
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameUstekinumabProduct NameSTELARA®Therapeutic AreaImmune System DiseasesEnrollment249% Female70.3%% WhiteN/A
Product ClassAntirheumatic Agents - Biologic Response ModifiersSponsor Protocol NumberC0743T06Data PartnerJohnson & JohnsonCondition StudiedMultiple SclerosisMean/Median Age (Years)39
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available